SLU-PP-332 is an experimental compound being explored in preclinical research for its potential role as a REV-ERB agonist. Early animal studies have investigated its impact on circadian rhythm regulation, metabolic function, and mitochondrial activity.
Each capsule contains 250mcg of SLU-PP-332, precisely dosed for consistent application in laboratory studies. Each bottle contains 60 capsules.
Key Features:
- 250mcg SLU-PP-332 per capsule
- 60 capsules per bottle
- Designed for stability and ease of use in research protocols
